A new U.S. House bill would put a moratorium on 340B hospital growth and impose a host of reporting requirements on 340B hospitals. It would also make it much harder for private nonprofit hospitals to remain in the 340B program.
As 340B Report first broke the news earlier this month, Rep. Matt Rosendale (R-Mont.) introduced the Drug Pricing Transparency and Accountability Act (H.R. 198) on Jan. 9, the first 340B bill to be introduced in the new session of Congress. The text was released last week. Rosendale filed a bill with the same title in October 2021. The two appear to be the same.
A new U.S. House bill would put a moratorium on 340B hospital growth and impose a host of reporting requirements on 340B hospitals. It would also make it much harder for private nonprofit hospitals to remain in the 340B program.
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
